Scaling patient engagement for deeper insights and better outcomes

 There are plenty of reasons to scale patient engagement. It drives a more patient-centric approach, can help create new services and enable better access and approval with payers and regulators.   But perhaps the simplest and most compelling reason for scaling engagement is its link to stronger outcomes, which has a cascade of business benefits.   “We should be doing this to get to better outcomes and that will also create a better commercial performance, because you will be in an environment where there is more money for innovation and you will be there with solutions that have a high outcome, so they will also have a high return,” says Daniel De Schryver, Patient Engagement and Advocacy Lead, EMEA, Janssen. “We need a mental shift where everybody understands that there was a way of doing business and we need to change it, for health economics, for outcomes, for commercial and societal reasons.” Barriers to changeA number of barriers to adopting or scaling patient engagement within organisations remain, including a limited awareness of the potential, entrenched cultures, lack of senior level buy-in or capabilities and challenges around regulatory and ethical frameworks.   Ensuring that people believe in the power of patient insights to lead to better outcomes will generate the enthusiasm needed to make changes, says Oliver Gassner, Head, Digital Health Intelligence, EMEA, Bayer.   “As a project manager, you’re faced with a decision of where to invest ...

Source: EyeForPharma - January 13, 2020 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news